Pharmacokinetics of Benaglutide Injection in Overweight/Obese Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 7, 2020

Primary Completion Date

December 1, 2020

Study Completion Date

May 20, 2021

Conditions
Overweight/Obese Adults
Interventions
DRUG

Benaglutide Injection

All subjects received multiple doses (tid) of 0.06 mg, 0.1 mg, 0.14 mg, and 0.2 mg in sequence, followed by the next dose after completing the previous multiple dosing. The administration time of each dose was 0.06 mg for 3 days, 0.1 mg for 3 days, 0.14 mg for 5 days, and 0.2 mg for 5 days.

Trial Locations (1)

266003

The Affiliated Hospital of Qingdao University, Qingdao

All Listed Sponsors
lead

The Affiliated Hospital of Qingdao University

OTHER

NCT05226000 - Pharmacokinetics of Benaglutide Injection in Overweight/Obese Adults | Biotech Hunter | Biotech Hunter